Mechanistically, linc00958 regulated miR-185-5p and RSF-1 and modulated cisplatin resistance in cervical cancer cells via targeting AKT1/GSK3β/VEGFA pathway (Tian et al., 2022). Here, VEGFA is linked to cervical carcinoma.